David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$696M |
| 2 |
Apple
AAPL
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$289M |
| 4 |
Keurig Dr Pepper
KDP
|
+$275M |
| 5 |
Meta Platforms (Facebook)
META
|
+$241M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$648M |
| 2 |
Merck
MRK
|
+$453M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$273M |
| 5 |
Broadcom
AVGO
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.15% |
| 2 | Consumer Discretionary | 12.62% |
| 3 | Healthcare | 10.65% |
| 4 | Financials | 9.26% |
| 5 | Industrials | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Canadian Imperial Bank of Commerce
CM
$108B
| $9.53M | 0.01% |
219,030
+186,236
| +568% | +$8.2M |
|
1077
PUT
APA Corp
APA
$14.6B
| $9.49M | 0.01% |
203,100
-59,600
| -23% | -$2.47M |
|
1078
Target
TGT
$74.1B
| $9.46M | 0.01% |
124,328
+37,016
| +42% | +$2.72M |
|
1079
CALL
Alcoa
AA
$13.5B
| $9.38M | 0.01% |
200,200
+49,500
| +33% | +$2.49M |
|
1080
Matador Resources
MTDR
$6.9B
| $9.38M | 0.01% |
312,029
-286,854
| -48% | -$8.65M |
|
|
SPLK
1081
CALL
DELISTED
Splunk Inc
SPLK
| $9.37M | 0.01% |
94,500
+74,500
| +373% | +$8.1M |
|
1082
BioCryst Pharmaceuticals
BCRX
$2.51B
| $9.36M | 0.01% |
1,633,872
+669,566
| +69% | +$3.69M |
|
1083
PUT
Snap-on
SNA
$20.4B
| $9.35M | 0.01% |
58,200
+40,900
| +236% | +$6.19M |
|
1084
Rambus
RMBS
$9.63B
| $9.35M | 0.01% |
745,238
-61,983
| -8% | -$838K |
|
|
ECYT
1085
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $9.34M | 0.01% |
677,003
-937,556
| -58% | -$11.1M |
|
1086
CALL
SLB Ltd
SLB
$79.3B
| $9.34M | 0.01% |
139,300
+9,200
| +7% | +$632K |
|
|
HES
1087
PUT
DELISTED
Hess
HES
| $9.33M | 0.01% |
139,500
+23,100
| +20% | +$1.38M |
|
1088
Photronics
PLAB
$1.73B
| $9.32M | 0.01% |
1,169,292
+247,543
| +27% | +$2.05M |
|
|
QUOT
1089
DELISTED
Quotient Technology Inc
QUOT
| $9.31M | 0.01% |
711,057
-5,122
| -0.7% | -$68.3K |
|
1090
RB Global
RBA
$15.7B
| $9.31M | 0.01% |
272,885
-54,315
| -17% | -$1.83M |
|
1091
Monolithic Power Systems
MPWR
$64.1B
| $9.3M | 0.01% |
69,602
+64,880
| +1,374% | +$8.26M |
|
1092
PUT
Boston Beer
SAM
$1.93B
| $9.29M | 0.01% |
+31,000
| New | +$7.55M |
|
1093
Modine Manufacturing
MOD
$10B
| $9.29M | 0.01% |
509,000
+131,824
| +35% | +$2.47M |
|
|
GHDX
1094
DELISTED
Genomic Health, Inc.
GHDX
| $9.25M | 0.01% |
183,622
+96,466
| +111% | +$3.83M |
|
|
CAJ
1095
DELISTED
Canon, Inc.
CAJ
| $9.25M | 0.01% |
282,855
+149,901
| +113% | +$5.18M |
|
1096
Shake Shack
SHAK
$3.01B
| $9.23M | 0.01% |
139,479
+117,548
| +536% | +$6.52M |
|
1097
Microchip Technology
MCHP
$40B
| $9.21M | 0.01% |
202,462
+197,296
| +3,819% | +$9.14M |
|
|
ELGX
1098
DELISTED
Endologix Inc
ELGX
| $9.19M | 0.01% |
162,397
-3,902
| -2% | -$198K |
|
1099
Usana Health Sciences
USNA
$252M
| $9.18M | 0.01% |
79,598
+4,508
| +6% | +$493K |
|
1100
Waters Corp
WAT
$40.7B
| $9.17M | 0.01% |
47,372
+34,440
| +266% | +$6.78M |
|
Similar funds
David Shaw's Q2 2018 Portfolio in Review
As of Q2 2018, David Shaw held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
- David Shaw added most to Amazon in Q2 2018, an estimated $696M increase.
- David Shaw's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
- David Shaw fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
- David Shaw's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
- David Shaw opened 622 new positions and closed 399 in Q2 2018.
- David Shaw's portfolio value rose 4.4% quarter-over-quarter to $76.7B.
Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.